ACP
CLNN icon

Acuta Capital Partners’s Clene CLNN Stock Holding History

Acuta Capital Partners’s Portfolio CLNN Stock Details CLNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-212,042
Closed -$3.73M – 49
2023
Q2 		$3.73M Buy
+212,042
New +$4.14M 2.53% 16

Other funds holding CLNN

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
SM
Scoggin Management New York $1.04B AUM 232.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LCM
Lunt Capital Management Holladay, Utah $260M AUM 10.98% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Acuta Capital Partners's CLNN Position: Q3 2023 in Review

Acuta Capital Partners sold out of Clene (CLNN) in Q3 2023, closing a stake of 212,042 shares — an estimated $3.73M sold.

Acuta Capital Partners first reported a position in CLNN in Q2 2023 and held it in 1 quarter. The position peaked at $3.73M in Q2 2023. 47 funds tracked by Wall St. Rank hold CLNN as of Q3 2023.

  • Acuta Capital Partners reported no remaining Clene position as of Q3 2023 after selling out during the quarter.
  • Acuta Capital Partners sold 212,042 Clene shares in Q3 2023, an estimated $3.73M.
  • Acuta Capital Partners first reported a position in Clene in Q2 2023 and held it in 1 quarter.
  • Acuta Capital Partners's Clene position peaked at $3.73M in Q2 2023.
  • 47 funds tracked by Wall St. Rank held Clene as of Q3 2023.

Based on Acuta Capital Partners's 13F filing for Q3 2023, filed 14 Nov 2023.